Nanopharm https://validator.w3.org/feed/docs/rss2.html Locations Leadership Team Clinical Trial Manufacturing Analytical Section cGMP Release & Stability Testing cGMP Release & Stability Testing Regulatory Consultancy Spray Drying and Particle Engineering Home Clinical Development Clinical Labeling About Us OINDP Expertise – Nasal Cast (Aeronose) Content Download | Exploring PBPK Modeling SmartTrack News & Events Nanopharm & Fluidda Discuss FDA’s New Inhaled Product Guidelines Accelerate DPI Clinical Success with Innovative De-Risking Strategy Interview with Rob Bootle: Advancements in Nanopharm’s OINDPs Driving Innovation in Inhaled and Nasal Drug Product Development Exploring PBPK Modeling in Nasal Drug Delivery: Expert Insights from Will Ganley Dry Powder Inhaler Formulations: Microstructural Analysis Techniques Interview with Jane Provis Evans, Head cGMP services at Nanopharm Scientific Publications Content Download | Interview with Jane Provis Evans, Head cGMP services at Nanopharm Nanopharm Announces Exclusive Collaboration With Fluidda To Accelerate Regulatory Pathway For OINDP Using SmartTrack Resources Content Download | Dry Powder Inhaler Formulations: Microstructural Analysis Techniques Careers Contact Posters White Papers Generic & LCM – Alternative Bioequivalence Content Download | Interview w/ Rob Bootle Content Download | RDD 2024 Content Download | Fireside Chat IVBE OINDP Expertise – Reformulation & Repositioning Content Download | Driving Innovation in Inhaled & Nasal Drug Product Development Generics & Lifecycle Management Inhaled Biologics OINDP Expertise – Nebulizers and Soft Mist Inhalers OINDP Expertise – Low GWP Propellants OINDP Expertise – Pressurized Metered-Dose Inhalers OINDP Expertise – Dry Powder Inhalers Dr. Will Ganley of Nanopharm & Dr. Jan De Backer of Fluidda Inhalation OINDP Expertise – Nasal Sprays (Liquids) OINDP Expertise – Nasal Powders OINDP Expertise Regulatory